Brandão Sofia Reis, Lazzari Elisa, Vitorino Rui, Meroni Germana, Reis-Mendes Ana, Neuparth Maria João, Amado Francisco, Carvalho Félix, Ferreira Rita, Costa Vera Marisa
Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal.
UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal.
Arch Toxicol. 2025 Mar 4. doi: 10.1007/s00204-025-04006-2.
Doxorubicin (DOX)-associated cardiotoxicity is characterized by long-term manifestations, whose mechanisms remain incompletely understood, and is exacerbated by various risk factors, with age being a prominent contributor. The objective of this study was to assess the enduring cardiac molecular impacts of DOX in old CD-1 male mice, focusing on ubiquitinated proteins. At 19 months of age, DOX group received a cumulative dose of 9.0 mg/kg of DOX, while control animals got saline solution. Animals were sacrificed 2 months after the administration. DOX induced heart structural changes and increased proteolytic activity. Additionally, increased protein ubiquitination was observed in DOX group, despite the decreased content of the E3 ubiquitin-protein ligase Atrogin-1. A search of poly-ubiquitinated proteins, enriched by tandem ubiquitin-binding entities (TUBEs), showed increased poly-ubiquitination of proteins associated with sarcomere organization and mitochondrial metabolism processes by DOX. Increased mitochondrial density inferred by higher citrate synthase activity was found in DOX group. Moreover, decreased biogenesis and auto(mito)phagy occurred in DOX animals, proven by decreased peroxisome proliferator-activated receptor γ coactivator 1 α, Beclin1 and microtubule-associated protein light chain 3 content. These findings indicate a reduction in mitochondrial biogenesis and accumulation of dysfunctional mitochondria in the aged heart, along with elevated levels of poly-ubiquitinated proteins after DOX treatment. Thus, the disruption of mitochondrial remodeling and impaired protein ubiquitination emerge as enduring consequences of DOX-induced cardiotoxicity, persisting for even 2 months after DOX exposure. This underscores the long-lasting impact of DOX, with significant effects continuing beyond the period of administration, which advocates for longer clinical surveillance.
阿霉素(DOX)相关的心脏毒性具有长期表现,其机制仍未完全明确,且会因多种风险因素而加剧,年龄是一个主要因素。本研究的目的是评估DOX对老年CD-1雄性小鼠心脏分子的持久影响,重点关注泛素化蛋白。19月龄时,DOX组接受累计剂量为9.0mg/kg的DOX,而对照动物接受生理盐水。给药2个月后处死动物。DOX诱导心脏结构改变并增加蛋白水解活性。此外,尽管E3泛素蛋白连接酶Atrogin-1的含量降低,但在DOX组中仍观察到蛋白泛素化增加。通过串联泛素结合实体(TUBEs)富集的多泛素化蛋白搜索显示,DOX使与肌节组织和线粒体代谢过程相关的蛋白多泛素化增加。DOX组中通过较高的柠檬酸合酶活性推断出线粒体密度增加。此外,DOX处理的动物中发生了生物合成和自噬减少,这通过过氧化物酶体增殖物激活受体γ共激活因子1α、Beclin1和微管相关蛋白轻链3含量的降低得到证实。这些发现表明,老年心脏中线粒体生物合成减少和功能失调的线粒体积累,以及DOX治疗后多泛素化蛋白水平升高。因此,线粒体重塑的破坏和蛋白泛素化受损是DOX诱导的心脏毒性的持久后果,甚至在DOX暴露后2个月仍持续存在。这强调了DOX的长期影响,其显著影响在给药期后仍持续存在,这提倡进行更长时间的临床监测。